This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Retrospective of Children With ADHD and Cardiac Symptoms

This study has been terminated.
(insufficient number of eligible subjects)
Information provided by:
Children's Healthcare of Atlanta Identifier:
First received: December 19, 2005
Last updated: July 5, 2011
Last verified: September 2007
There is some evidence suggesting ADHD medication interaction could result in mild myocardial ischemia/infarct.

Congenital Disorders

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: A Retrospective Study of Children With ADHD and Cardiac Symptoms

Further study details as provided by Children's Healthcare of Atlanta:

Enrollment: 10
Study Start Date: January 1999
Study Completion Date: September 2007
Detailed Description:

Children with no previous cardiac history who have been on Adderall for ADHD, have developed acute cardiac symptoms after the addition of Straterra for the treatment of ADHD.

We wish to do a study of the medication interactions of Straterra and other ADHD medications focusing on the cardiac manifestations.

We will collect the following information on each patient: Medical Record Number, Account number, Dates of Admission, Discharge, Treatment or Death, Information Regarding Cardiac Signs and Symptoms, Medication Information, Age, Weight, Diagnoses


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
retro chart review

Inclusion Criteria:

  • ADHD
  • myocardial ischemia/infarct
  • no previous cardiac history
  • added Straterra
  • already taking Adderall

Exclusion Criteria:

  • those who do not meet inclusion criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00266955

United States, Georgia
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Children's Healthcare of Atlanta
Principal Investigator: Martha Clabby, MD Children's Healthcare of Atlanta
  More Information Identifier: NCT00266955     History of Changes
Other Study ID Numbers: 04-111
Study First Received: December 19, 2005
Last Updated: July 5, 2011

Keywords provided by Children's Healthcare of Atlanta:
Straterra processed this record on August 21, 2017